Algernon Pharmaceuticalsinc (AGN.CN)
0.0850 x 12000 0.1000 x 10000
Post-market by (Cboe BZX)
0.0900 unch (unch) 03/21/25 [CNSX]
0.0850 x 12000 0.1000 x 10000
Post-market 0.0900 unch (unch) 13:44 ET
for Fri, Mar 21st, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 08/31
(Values in thousands)
| 11-2024 | 08-2024 | 05-2024 | 02-2024 | 11-2023 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 6 | 5 | 6 | 8 | 7 |
| Accounts receivable | 2 | -6 | 22 | -17 | 82 |
| Other Working Capital | 113 | -221 | -1,384 | 607 | 382 |
| Other Operating Activity | -365 | -410 | -430 | -837 | -523 |
| Operating Cash Flow | $-244 | $-632 | $-1,786 | $-239 | $-52 |
| Cash Flows From Investing Activities | |||||
| Purchase Sale Intangibles | N/A | -31 | 2,685 | -23 | 0 |
| Other Investing Activity | 0 | 27 | 2,337 | 0 | 0 |
| Investing Cash Flow | $N/A | $-4 | $2,307 | $-23 | $0 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 628 | 0 | N/A | N/A |
| Other Financing Activity | 0 | 0 | 8 | 266 | 0 |
| Financing Cash Flow | $0 | $628 | $8 | $266 | $0 |
| Exchange Rate Effect | 6 | -5 | 4 | -1 | 1 |
| Beginning Cash Position | 596 | 610 | 76 | 74 | 125 |
| End Cash Position | 358 | 596 | 610 | 76 | 74 |
| Net Cash Flow | $-244 | $-9 | $529 | $3 | $-52 |
| Free Cash Flow | |||||
| Operating Cash Flow | -244 | -632 | -1,786 | -239 | -52 |
| Capital Expenditure | N/A | -31 | -30 | N/A | N/A |
| Free Cash Flow | -244 | -664 | -1,815 | -239 | -52 |